Gourbault Amanda Mandy

CMPO CRO Amanda Mandy sold 85,365 shares at $19.02 for $1,623,642.30 on 2025-08-13

Chief Revenue Officer Amanda Mandy sold 85,365 shares (9.6% of her pre-transaction holdings) at $19.02, reducing her position from 885,033 to 799,668 shares. The sale occurred within 3 basis points of the 52-week high of $19.45, and the stock has appreciated 36.2% over the prior 30 days and 52.0% over the prior 90 days. However, her prior open-market sell at this ticker on 2024-08-14 had a 90-day return of +28.4%, meaning the stock rose after that sale—a poorly-timed outcome. CompoSecure remains unprofitable with net income of $-26,125,000.00 for the most recent full fiscal year, though revenue grew 7.7% annually. The CRO's sale at near-peak prices during a strong momentum period warrants investor attention to whether this reflects confidence limits or other operational considerations.

CMPO CRO Amanda Mandy sold 130,859 shares at $11.08; holdings now 908,641 shares (-12.6%)

Amanda Mandy, Chief Revenue Officer of CompoSecure, sold 130,859 shares at $11.08 on 2024-08-14, reducing her holdings by 12.6% to 908,641 shares and raising $1,449,917.72. The sale occurred at the 52-week high of $11.08, following a 30-day gain of +44.8% and a 90-day gain of +67.6%, suggesting the sale was executed at a local peak in recent price action. With a P/E of 29.95 and annual revenue growth of only 3.2%, the valuation may not reflect modest organic growth, and a CRO's discretionary sale of a meaningful portion of holdings warrants investor attention to revenue trajectory and confidence signals in the executive suite.